Avery Dennison announced that it has acquired Finesse Medical Ltd., an innovator in the development and manufacture of healthcare products used in the management of wound care and skin conditions.
 
Headquartered in Longford, Ireland, Finesse Medical specializes in the development and application of advanced technologies in wound care and skin treatment, including skin barrier films and protection creams, and silicone and polyurethane foam wound dressings. With revenue over the last year of approximately €15 million, the company is a supplier to global healthcare-product OEMs and also provides contract manufacturing and product development services.
 
“Finesse Medical is a top quality manufacturer with a strong track record for developing and commercializing effective, high-value products in the medical sector,” said Mitch Butier, Avery Dennison’s president and CEO. “This acquisition will accelerate the achievement of our long-term strategic and financial goals for our industrial and healthcare materials segment.”
 
“Finesse Medical is a great strategic fit with Vancive Medical Technologies,” added Mike Johansen, VP and GM of Avery Dennison’s Industrial and Healthcare Materials group. “Its innovative portfolio of silicone gels and polyurethane foam dressings builds on and complements our existing products in wound care. And its converting and packaging capabilities will enable us to offer expanded manufacturing services to our customers.”